EcoDrugPlus

Malt1 Paracaspase

Ensembl ID : ENSELUG00000014717
Gene Symbol: MALT1
3 Cross references
198 Possible Orthologues:

Map Kinase-Interacting Serine/threonine-Protein Kinase 2

Ensembl ID : ENSELUG00000000430
Gene Symbol: LOC105006075
3 Cross references
156 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSELUG00000014380
Gene Symbol: MAPKAPK2
1 Cross references
183 Possible Orthologues:

Mapk Interacting Serine/threonine Kinase 2

Ensembl ID : ENSELUG00000014125
Gene Symbol: MKNK2
3 Cross references
208 Possible Orthologues:

Mdm2 Proto-Oncogene

Ensembl ID : ENSELUG00000013606
Gene Symbol: MDM2
3 Cross references
285 Possible Orthologues:

Met Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSELUG00000012486
Gene Symbol: MET
3 Cross references
205 Possible Orthologues:

Mtor Associated Protein, Lst8 Homolog

Ensembl ID : ENSELUG00000000801
Gene Symbol: MLST8
2 Cross references
195 Possible Orthologues:

N-Acetylated Alpha-Linked Acidic Dipeptidase 2

Ensembl ID : ENSELUG00000011396
Gene Symbol: NAALAD2
1 Cross references
340 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSELUG00000033016
Gene Symbol: LOC114828786
2 Cross references
157 Possible Orthologues:

Nad(P)h Dehydrogenase, Quinone 1

Ensembl ID : ENSELUG00000016240
Gene Symbol: NQO1
1 Cross references
153 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSELUG00000005135
Gene Symbol: NQO1
1 Cross references
157 Possible Orthologues:

Nad(P)h Quinone Dehydrogenase 1

Ensembl ID : ENSELUG00000005112
Gene Symbol: NQO1
1 Cross references
157 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).